We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMPV
1401
DELISTED
Imperva, Inc.
IMPV
| $260K | 0.01% |
+4,117
| New | +$280K |
|
|
POM
1402
DELISTED
PEPCO HOLDINGS, INC.
POM
| $259K | 0.01% |
9,938
-12,427
| -56% | -$326K |
|
1403
Rithm Capital
RITM
$5.46B
| $258K | 0.01% |
21,202
-20,336
| -49% | -$251K |
|
1404
Teekay
TK
$981M
| $258K | 0.01% |
26,107
-686
| -3% | -$17.9K |
|
|
MSCC
1405
DELISTED
Microsemi Corp
MSCC
| $258K | 0.01% |
+7,910
| New | +$279K |
|
1406
DigitalBridge
DBRG
$2.93B
| $257K | 0.01% |
5,290
-16,890
| -76% | -$909K |
|
|
MODV
1407
DELISTED
ModivCare
MODV
| $257K | 0.01% |
+5,472
| New | +$263K |
|
1408
Sonida Senior Living
SNDA
$2.04B
| $257K | 0.01% |
+821
| New | +$273K |
|
|
SFLY
1409
DELISTED
Shutterfly, Inc.
SFLY
| $257K | 0.01% |
+5,770
| New | +$248K |
|
1410
LiveRamp
RAMP
$2.29B
| $256K | 0.01% |
12,245
-1,083
| -8% | -$23.6K |
|
|
KW
1411
DELISTED
Kennedy-Wilson Holdings
KW
| $255K | 0.01% |
10,612
-16,914
| -61% | -$416K |
|
|
LTRPA
1412
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $255K | 0.01% |
+8,384
| New | +$247K |
|
|
NTRI
1413
DELISTED
NutriSystem, Inc.
NTRI
| $255K | 0.01% |
11,799
-8,229
| -41% | -$194K |
|
1414
Sonoco
SON
$5.99B
| $254K | 0.01% |
6,221
-26,909
| -81% | -$1.12M |
|
|
TBI
1415
Trueblue
TBI
$235M
| $254K | 0.01% |
9,852
-3,246
| -25% | -$87.6K |
|
|
BWLD
1416
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $254K | 0.01% |
+1,592
| New | +$265K |
|
1417
Interface
TILE
$2B
| $253K | 0.01% |
13,235
-25,707
| -66% | -$531K |
|
1418
Vermilion Energy
VET
$1.59B
| $253K | 0.01% |
+9,321
| New | +$293K |
|
1419
CDW
CDW
$18.4B
| $252K | 0.01% |
6,002
-25,868
| -81% | -$1.13M |
|
1420
Hubbell
HUBB
$25.6B
| $251K | 0.01% |
+2,483
| New | +$253K |
|
1421
Adtran
ADTN
$730M
| $250K | 0.01% |
+14,530
| New | +$231K |
|
|
VSI
1422
DELISTED
Vitamin Shoppe Inc.
VSI
| $250K | 0.01% |
+7,637
| New | +$242K |
|
|
CLNY
1423
DELISTED
Colony Capital, Inc.
CLNY
| $250K | 0.01% |
12,860
-162,289
| -93% | -$3.3M |
|
|
CAVM
1424
DELISTED
Cavium, Inc.
CAVM
| $250K | 0.01% |
3,809
-4,446
| -54% | -$300K |
|
|
TRCO
1425
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $250K | 0.01% |
7,381
-25,375
| -77% | -$948K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.